Manuscript published in Stem Cell Reviews and Reports
Technology transfer on cell therapy to Vietnam by GN Corporation leads to new opportunities
Webiner on Cell Therapy Approaches for Urethral Stricture is held on 16 OCt 2022
A look at the potential of beta-glucan for the growing number of non-alcoholic fatty liver diseases
Paper on potential of beta glucan products is pubrished
The paper is published in Scientific Reports, Nature Journal
GNC’s activities are introduced in the Japan Cabinet Office’s site
This is the research on the potential of beta-glucan for
A breakthrough achievement on miRNA140 is published in Medicine Innovates
GN Corporation Co Ltd obtained a Japanese patent N…
Obtained Japanese patent for Urethral Stricture Treatment
